Head to Head Comparison: Dazed (OTCMKTS:MEDH) & Accolade (NASDAQ:ACCD)

Dazed (OTCMKTS:MEDH) and Accolade (NASDAQ:ACCD) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, profitability, analyst recommendations, institutional ownership, earnings, valuation and dividends.

Volatility and Risk

Dazed has a beta of 3.13, indicating that its share price is 213% more volatile than the S&P 500. Comparatively, Accolade has a beta of 2.08, indicating that its share price is 108% more volatile than the S&P 500.

Profitability

This table compares Dazed and Accolade’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Dazed	-55.24%	N/A	N/A
Accolade	-18.16%	-18.43%	-10.35%

Institutional and Insider Ownership

85.0% of Accolade shares are owned by institutional investors. 8.2% of Accolade shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Valuation & Earnings

This table compares Dazed and Accolade”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Dazed	$450,000.00	N/A	N/A	N/A	N/A
Accolade	$441.03 million	1.25	-$99.81 million	($1.03)	-6.66

Dazed has higher earnings, but lower revenue than Accolade.

Analyst Ratings

This is a summary of current ratings and recommmendations for Dazed and Accolade, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Dazed	0	0	0	0	0.00
Accolade	0	6	5	0	2.45

Accolade has a consensus price target of $7.65, suggesting a potential upside of 11.52%. Given Accolade’s stronger consensus rating and higher probable upside, analysts clearly believe Accolade is more favorable than Dazed.

Summary

Accolade beats Dazed on 7 of the 10 factors compared between the two stocks.

About Dazed

Dazed, Inc. focuses on retail, distribution, hospitality, licensing, and franchising of portfolio of counterculture brands. The company was formerly known as MedX Holdings, Inc. and changed its name to Dazed, Inc. in October 2022. Dazed, Inc. was founded in 2004 and is based in Cheyenne, Wyoming.

About Accolade

Accolade, Inc., together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based intelligent technology and multimodal support from a team of advocates and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women’s health specialists, case management specialists, expert medical opinion providers, and primary care physicians. It also provides medical opinion services to commercial customers; and navigation, care, and advocacy solutions. In addition, the company offers medical consultations that connect patients to qualified condition-specific specialists for adult and pediatric care; and primary care and mental health support solutions. It serves employers who provide employees and their families a single place to turn for their health, healthcare, and benefits needs. The company was incorporated in 2007 and is headquartered in Seattle, Washington.